John Chia

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source: MECFS Alert

Dr. John K. S. Chia is an infectious disease doctor with a medical practice in Torrance, California. Dr. Chia became heavily involved in research and clinical care of myalgic encephalomyelitis (ME) and chronic fatigue syndrome (CFS) patients after his son, Andrew Chia, became ill with CFS in 1997. He has published several papers[1] on infectious causes of ME and CFS, including evidence of involvement of enteroviruses such as coxsackie B and echovirus, other viruses such as parvovirus B19, as well as bacteria such as Chlamydia pneumoniae. In addition to his clinical work, he runs his own enterovirus research laboratory[2] and is on the board of directors of the Enterovirus Foundation.

Dr. Chia has performed clinical trials[3] in an attempt to find treatment for patients with ME and CFS. His treatment attempts have focused on the use of antiviral compounds such as amantadine, ribavirin, and lamivudine in addition to immune modulators such as interferon and the plant compound oxymatrine. Towards this end, he and his son, a pharmacist, have developed his own proprietary herbal preparation containing oxymatrine and other plant compounds, called Equilibrant.

International Consensus Criteria[edit | edit source]

Dr. Chia co-authored the 2011 case definition, International Consensus Criteria.[4]


Open Letter to The Lancet[edit | edit source]

Three open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Chia, along with 41 colleagues in the ME/CFS field, signed the second letter. In 2018, Dr. Chia was joined with over 100 signatories.

Notable studies[edit | edit source]

Talks and interviews[edit | edit source]

Media coverage[edit | edit source]

Publications[edit | edit source]

  • 2003, Correspondence in Clinical Infectious Diseases - "Diverse Etiologies for Chronic Fatigue Syndrome"[13]

Online presence[edit | edit source]

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. http://www.ncbi.nlm.nih.gov/pubmed/?term=chia+jk%5Bauthor%5D
  2. EVMED Research
  3. Ribavirin and Interferon-a for the Treatment of Patients with Chronic Fatigue Syndrome Associated with Persistent Coxsackievirus B Infection: A Preliminary Observation
  4. Carruthers, Bruce M.; van de Sande, Marjorie I.; De Meirleir, Kenny L.; Klimas, Nancy G.; Broderick, Gordon; Mitchell, Terry; Staines, Donald; Powles, A. C. Peter; Speight, Nigel; Vallings, Rosamund; Bateman, Lucinda; Baumgarten-Austrheim, Barbara; Bell, David; Carlo-Stella, Nicoletta; Chia, John; Darragh, Austin; Jo, Daehyun; Lewis, Donald; Light, Alan; Marshall-Gradisnik, Sonya; Mena, Ismael; Mikovits, Judy; Miwa, Kunihisa; Murovska, Modra; Pall, Martin; Stevens, Staci (August 22, 2011). "Myalgic encephalomyelitis: International Consensus Criteria". Journal of Internal Medicine. 270 (4): 327–338. doi:10.1111/j.1365-2796.2011.02428.x. ISSN 0954-6820. PMC 3427890. PMID 21777306.
  5. Tuller, David (February 10, 2016). "An open letter to The Lancet, again".
  6. Tuller, David (June 19, 2018). "Trial By Error: An Open Letter to The Lancet, Two Years On".
  7. Chia, John K (2004). "Ribavirin and Interferon-α for the Treatment of Patients with Chronic Fatigue Syndrome Associated with Persistent Coxsackievirus B Infection: A Preliminary Observation" (PDF). The Journal of Applied Research. 4.
  8. Chia, JKS (2005). "The role of enterovirus in chronic fatigue syndrome". J Clin Pathol. 58 (11): 1126–32. doi:10.1136/jcp.2004.020255. PMID 16254097.
  9. Chia, John; Chia, Andrew (2008). "Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach". Journal of Clinical Pathology. 61 (1): 43–48.
  10. Kerr, J. R.; Gough, J.; Richards, S. C. M.; Main, J.; Enlander, D.; McCreary, M.; Komaroff, A. L.; Chia, J. K. (April 1, 2010). "Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis". Journal of General Virology. 91 (4): 893–897. doi:10.1099/vir.0.017590-0. ISSN 0022-1317.
  11. "Dr Chia's ME/CFS post-mortem brain study: Chronic Enterovirus Infection in a Patient With Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (ME/CFS) – Clinical, Virologic and Pathological Analysis. John Chia, David Wang, Andrew Chia, Rabiha El-Habbal, 2015. Presented at the 19th International Picornavirus Meeting, 2016".
  12. Chia, John K.; Chia, Andrew Y.; Wang, David; El-Habbal, Rabiha (2015), "Functional Dyspepsia and Chronic Gastritis Associated with Enteroviruses", Open Journal of Gastroenterology, 5 (4): 21-27., doi:10.4236/ojgas.2015.54005
  13. Chia, John K.S.; Chia, Andrew (2003), "Diverse Etiologies for Chronic Fatigue Syndrome", Clinical Infectious Diseases, 36 (5): 671-672, doi:10.1086/367666

myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

α α / Α. Greek letter alpha or alfa (symbol), equivalent to "a".

antibodies Antibodies or immunoglobulin refers to any of a large number of specific proteins produced by B cells that act against an antigen in an immune response.

enterovirus A genus of RNA viruses which typically enter the body through the respiratory or gastrointestinal systems and sometimes spread to the central nervous system or other parts of the body, causing neurological, cardiac, and other damage. Since the first reports of myalgic encephalomyelitis (ME), enteroviruses have been suspected as a cause of ME. Enteroviruses have also been implicated as the cause of Type I diabetes, congestive heart failure, and other conditions. Enteroviruses include poliovirus, coxsackieviruses, and many others. New enteroviruses and new strains of existing enteroviruses are continuously being discovered. (Learn more: viralzone.expasy.org)

myalgic encephalomyelitis (ME) - A disease often marked by neurological symptoms, but fatigue is sometimes a symptom as well. Some diagnostic criteria distinguish it from chronic fatigue syndrome, while other diagnostic criteria consider it to be a synonym for chronic fatigue syndrome. A defining characteristic of ME is post-exertional malaise (PEM), or post-exertional neuroimmune exhaustion (PENE), which is a notable exacerbation of symptoms brought on by small exertions. PEM can last for days or weeks. Symptoms can include cognitive impairments, muscle pain (myalgia), trouble remaining upright (orthostatic intolerance), sleep abnormalities, and gastro-intestinal impairments, among others. An estimated 25% of those suffering from ME are housebound or bedbound. The World Health Organization (WHO) classifies ME as a neurological disease.

enterovirus A genus of RNA viruses which typically enter the body through the respiratory or gastrointestinal systems and sometimes spread to the central nervous system or other parts of the body, causing neurological, cardiac, and other damage. Since the first reports of myalgic encephalomyelitis (ME), enteroviruses have been suspected as a cause of ME. Enteroviruses have also been implicated as the cause of Type I diabetes, congestive heart failure, and other conditions. Enteroviruses include poliovirus, coxsackieviruses, and many others. New enteroviruses and new strains of existing enteroviruses are continuously being discovered. (Learn more: viralzone.expasy.org)

enterovirus A genus of RNA viruses which typically enter the body through the respiratory or gastrointestinal systems and sometimes spread to the central nervous system or other parts of the body, causing neurological, cardiac, and other damage. Since the first reports of myalgic encephalomyelitis (ME), enteroviruses have been suspected as a cause of ME. Enteroviruses have also been implicated as the cause of Type I diabetes, congestive heart failure, and other conditions. Enteroviruses include poliovirus, coxsackieviruses, and many others. New enteroviruses and new strains of existing enteroviruses are continuously being discovered. (Learn more: viralzone.expasy.org)

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.